Clinical Trial Update: OrACELL™ vs. Connective Tissue in Miller Class 3 Defects [NA]

View source ↗

Summary

A completed clinical trial comparing OrACELL to connective tissue graft for Miller Class 3 gingival recession defects.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gingival Recession

Drugs mentioned

• OrACELL

Snippet

Sponsor: Texas A&M University | Conditions: Gingival Recession | NA | Status: COMPLETED